跳至主要内容
临床试验/CTRI/2020/04/024945
CTRI/2020/04/024945已完成不适用

Effects of tamsulosin and tamsulosin + solifenacin combination therapy in treatment of ureteral stent related lower urinary tract symptoms.

ankit1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2020年1月5日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
100
试验地点
1
主要终点
2.visual analogue pain scale

研究概览

简要总结

To analyse the effectiveness of selective alpha -1-blocker tamsulosin and combination of alpha -1-blocker  tamsulosin plus competitve muscarinic receptor antagonist solifenacin in improving the lower urinary tract symptoms of patients  with double J  ureteral stents

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc

入排标准

年龄范围
18.00 Year(s) 至 80.00 Year(s)(—)
性别
All

入选标准

  • Patients undergoing Double-J stenting for ureteral intervention were included in the study.

排除标准

  • 1-Patients who were previously diagnosed with benign prostatic hyperplasia or overactive bladder.
  • 2-Pregnant women.
  • 3- Psychiatric illness 4-Urinary tract infections.
  • 5-Previous use of selective alpha-1- blocker and or antimuscarinic agent or with known history of orthostatic hypotension,allergy,hypersensitivity to one or more alpha blockers.
  • 6-Patients under ICU management 7-Patients on dialysis.

结局指标

主要结局

2.visual analogue pain scale

时间窗: 1. On the day of PER URETHRAL CATHETER REMOVAL | 2.On the day of DJ stent removal

1. International Prostate Symptom Score/quality of life

时间窗: 1. On the day of PER URETHRAL CATHETER REMOVAL | 2.On the day of DJ stent removal

次要结局

  • 1. STORAGE SYMPTOMS IMPROVEMENT(2. VOIDING SYMPTOMS IMPROVEMENT)

研究者

发起方
ankit
申办方类型
Other [self]

研究点 (1)

Loading locations...

相似试验